SCHEMBL8008685

SCHEMBL8008685

CCOc1ccccc1N/C=C1\C(=O)N(c2ccc(S(=O)(=O)N(CC)CC)cc2)N=C1CCCC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.43
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 7/20 0.38
GAA P10253 1/20 0.38
HTT P42858 3/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
CYP2C19 P33261 1/20 0.36
PTGS2 P35354 1/20 0.36
PKM P14618 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RAB9A P51151 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MDM4 O15151 1/20 0.35
MDM2 Q00987 1/20 0.35
POLB P06746 1/20 0.35
RECQL P46063 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8008686 1.00 THRB (0.43) THRBKMT2AALDH1A1GAAHTT
SCHEMBL6947834 0.91 THRB (0.44) THRBKMT2AALDH1A1GAAHTT
SCHEMBL6947838 0.91 THRB (0.44) THRBKMT2AALDH1A1GAAHTT
SCHEMBL8009327 0.89 MAPT (0.37) THRBKMT2AALDH1A1HTTMEN1
SCHEMBL8009323 0.89 MAPT (0.37) THRBKMT2AALDH1A1HTTMEN1
SCHEMBL6953328 0.86 ALDH1A1 (0.47) THRBKMT2AALDH1A1GAAHTT
SCHEMBL6953331 0.86 ALDH1A1 (0.47) THRBKMT2AALDH1A1GAAHTT
SCHEMBL6949544 0.84 PTGS2 (0.47) THRBKMT2AALDH1A1GAAHTT
SCHEMBL6949542 0.84 PTGS2 (0.47) THRBKMT2AALDH1A1GAAHTT
SCHEMBL8008689 0.82 THRB (0.40) THRBKMT2AALDH1A1GAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US claimed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed